Helix Biopharma Corp.TSX: HBP

Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts

Nov 5, 2009 at 10:38 PM UTC · Issued by Helix Biopharma Corp. via CNW

Nov. 5, 2009 (Canada NewsWire Group) --

AURORA, Ontario, Nov. 5 /CNW/ --